|
1
|
American Cancer Society, . Cancer Facts
& Figures 2013. American Cancer Society; Atlanta: 2013,
http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf
|
|
2
|
Zarogoulidis K, Zarogoulidis P, Darwiche
K, Boutsikou E, Machairiotis N, Tsakiridis K, Katsikogiannis N,
Kougioumtzi I, Karapantzos I, Huang H and Spyratos D: Treatment of
non-small cell lung cancer (NSCLC). J Thorac Dis. 5 Suppl
4:S389–S396. 2013.PubMed/NCBI
|
|
3
|
Miller KD, Siegel RL, Lin CC, Mariotto AB,
Kramer JL, Rowland JH, Stein KD, Alteri R and Jemal A: Cancer
treatment and survivorship statistics, 2016. CA Cancer J Clin.
66:271–289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vineis P and Wild CP: Global cancer
patterns: Causes and prevention. Lancet. 383:549–557. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sridhar SS, Seymour L and Shepherd FA:
Inhibitors of epidermal growth-factor receptors: A review of
clinical research with a focus on non-small-cell lung cancer.
Lancet Oncol. 4:397–406. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grossi F, Gridelli C, Aita M and De
Marinis F: Identifying an optimum treatment strategy for patients
with advanced non-small cell lung cancer. Crit Rev Oncol Hematol.
67:16–26. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Otterson GA, Villalona-Calero MA, Hicks W,
Pan X, Ellerton JA, Gettinger SN and Murren JR: Phase I/II study of
inhaled doxorubicin combined with platinum-based therapy for
advanced non-small cell lung cancer. Clin Cancer Res. 16:2466–2473.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pilkington G, Boland A, Brown T, Oyee J,
Bagust A and Dickson R: A systematic review of the clinical
effectiveness of first-line chemotherapy for adult patients with
locally advanced or metastatic non-small cell lung cancer. Thorax.
70:359–367. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Beecher GR, Warden BA and Merken H:
Analysis of tea polyphenols. Proc Soc Exp Biol Med. 220:pp.
267–270. 1999, View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Formica JV and Regelson W: Review of the
biology of Quercetin and related bioflavonoids. Food Chem Toxicol.
33:1061–1080. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hollman PC and Katan MB: Dietary
flavonoids: Intake, health effects and bioavailability. Food Chem
Toxicol. 37:937–942. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gupta A, Birhman K, Raheja I, Sharma SK
and Kar HK: Quercetin: A wonder bioflavonoid with therapeutic
potential in disease management. Asian Pac J Trop Dis. 6:248–252.
2016. View Article : Google Scholar
|
|
13
|
Park MH and Min do S: Quercetin-induced
downregulation of phospholipase D1 inhibits proliferation and
invasion in U87 glioma cells. Biochem Biophys Res Commun.
412:710–715. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zheng SY, Li Y, Jiang D, Zhao J and Ge JF:
Anticancer effect and apoptosis induction by quercetin in the human
lung cancer cell line A-549. Mol Med Rep. 5:822–826.
2012.PubMed/NCBI
|
|
15
|
David Anand AV, Arulmoli R and Parasuraman
S: Overviews of biological importance of quercetin: A bioactive
flavonoid. Pharmacogn Rev. 10:84–89. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lugli E, Ferraresi R, Roat E, Troiano L,
Pinti M, Nasi M, Nemes E, Bertoncelli L, Gibellini L, Salomoni P,
et al: Quercetin inhibits lymphocyte activation and proliferation
without inducing apoptosis in peripheral mononuclear cells. Leuk
Res. 33:140–150. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gibellini L, Pinti M, Nasi M, Montagna JP,
Biasi SD, Roat E, Bertoncelli E, Cooper EL and Cossarizza A:
Quercetin and cancer chemoprevention. Evid Based Compl Altern Med.
1011:5913562011.
|
|
18
|
Puoci F, Morelli C, Cirillo G, Curcio M,
Parisi OI, Maris P, Sisci D and Picci N: Anticancer activity of a
quercetin-based polymer towards HeLa cancer cells. Anticancer Res.
32:2843–2847. 2012.PubMed/NCBI
|
|
19
|
Tran TH, Ramasamy T, Truong DH, Shin BS,
Choi HG, Yong CS and Kim JO: Development of vorinostat-loaded solid
lipid nanoparticles to enhance pharmacokinetics and efficacy
against multidrug-resistant cancer cells. Pharm Res. 31:1978–1988.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ramasamy T, Choi JY, Cho HJ, Umadevi SK,
Shin BS, Choi HG, Yong CS and Kim JO: Polypeptide-based Micelles
for Delivery of Irinotecan: Physicochemical and in vivo
characterization. Pharm Res. 32:1947–1956. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ramasamy T, Ruttala HB, Gupta B, Poudel
BK, Choi HG, Yong CS and Kim JO: Smart chemistry-based nanosized
drug delivery systems for systemic applications: A comprehensive
review. J Control Release. 258:226–253. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Choi JY, Ramasamy T, Kim SY, Kim J, Ku SK,
Youn YS, Kim JR, Jeong JH, Choi HG, Yong CS and Kim JO: PEGylated
lipid bilayer-supported mesoporous silica nanoparticle composite
for synergistic co-delivery of axitinib and celastrol in
multi-targeted cancer therapy. Acta Biomater. 39:94–105. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ramasamy T, Kim J, Choi HG, Yong CS and
Kim JO: Novel dual drug-loaded block ionomer complex micelles for
enhancing the efficacy of chemotherapy treatments. J Biomed
Nanotechnol. 10:1304–1312. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tran TH, Ramasamy T, Choi JY, Nguyen HT,
Pham TT, Jeong JH, Ku SK, Choi HG, Yong CS and Kim JO:
Tumor-targeting, pH-sensitive nanoparticles for docetaxel delivery
to drug-resistant cancer cells. Int J Nanomedicine. 10:5249–5262.
2015.PubMed/NCBI
|
|
25
|
Zhou X, Luo S, Tang R, Wang R and Wang J:
Diblock copolymers of polyethylene glycol and a polymethacrylamide
with side-chains containing twin ortho ester rings: Synthesis,
characterization, and evaluation as potential pH-responsive
micelles. Macromol Biosci. 15:385–394. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Corvazier E and Maclouf J: Interference of
some flavonoids and non-steroidal anti-inflammatory drugs with
oxidative metabolism of arachidonic acid by human platelets and
neutrophils. Biochim Biophys Acta. 835:315–321. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pan G, Lemmouchi Y, Akala EO and Bakare O:
Studies on PEGylated and drug-loaded PAMAM dendrimers. J Bioact
Compat Polym. 20:113–128. 2005. View Article : Google Scholar
|
|
28
|
Yamazaki M and Ito T: Deformation and
instability in membrane structure of phospholipid vesicles caused
by osmophobic association: Mechanical stress model for the
mechanism of poly(ethylene glycol)-induced membrane fusion.
Biochemistry. 29:1309–1314. 1990. View Article : Google Scholar : PubMed/NCBI
|
